In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Zydus Lifesciences Ltd
-(ZYDUSLIFE)
XNSE:ZYDUSLIFE, XBOM:ZYDUSLIFE
Zydus Lifesciences Ltd Q4FY24; 248% rise in Profits
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Zydus Lifesciences Ltd Q3 FY24 Earnings Conference Call Insights
Key highlights from Zydus Lifesciences Ltd (ZYDUSLIFE) Q3 FY24 Earnings Concall India Formulations Double-digit growth led by volume expansion and new launches.
Zydus Lifesciences Ltd Q2FY24; 53% rise in Profits
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Zydus Lifesciences Ltd Q1FY24; 97% rise in Profits
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Zydus Lifesciences Ltd (ZYDUSLIFE) Q4 FY23 Earnings Concall Transcript
Zydus Lifesciences Ltd (NSE: ZYDUSLIFE) Q4 FY23 earnings concall dated May. 18, 2023 Corporate Participants: Ganesh Nayak -- Executive Director Sharvil Patel -- Managing Director Nitin
Zydus Lifescience Ltd Q4FY23 results out, revenue grows by 32%
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Zydus lifescience net profit soars by 23% in Q3FY23
Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third quarter ended
Zydus Lifesciences Ltd (ZYDUSLIFE) Q3 FY23 Earnings Concall Transcript
Zydus Lifesciences Ltd (NSE:ZYDUSLIFE) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Ganesh N. Nayak -- Executive Director Sharvil P. Patel -- Managing Director
Zydus Lifesciences Q3FY23 net profit rises by 23%; Revenue soars 20%
Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third quarter ended
Five stocks that you can gift your children
Let’s start with a simple “What am I” type riddle - “Sometimes I stink. Sometimes I'm dirty. Yet everyone wants me.” Now
Zydus Lifesciences Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/R4mbpNYrIhE Key highlights from Zydus Lifesciences Ltd (ZYDUSLIFE) Q1 FY23 Earnings Concall Q&A Highlights: Neha enquired about the drivers of strong growth
Zydus Lifesciences Ltd Q1FY23; Profit suffer with rise in expenses
Revenue for Q1 FY23 has increased by 1.8% YoY to ₹40,727 millions. Profits decreased by 12% YoY to ₹5,183 millions because Total